Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bausch & Lomb
Biotech
Eye disease biotech looks to clinical trials with $93M series B
Character Biosciences' proceeds will fund phase 1 and phase 2 trials of its lead AMD assets and expand its pipeline into other eye diseases.
Darren Incorvaia
Mar 25, 2025 8:00am
Bausch + Lomb pens $485M-plus biobucks pact with City Tx
Jan 10, 2025 6:37am
Eikon builds out clinical development team—Chutes & Ladders
Jun 2, 2023 9:30am
Bausch + Lomb exec to depart—Chutes & Ladders
Apr 14, 2023 9:30am
Sanofi's John Reed jumps ship for J&J—Chutes & Ladders
Feb 17, 2023 9:30am
Bausch + Lomb buys cataract lens maker AcuFocus
Jan 20, 2023 11:42am